ALSPT Fundamental Analysis - SPARTOO

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALSPT. ALSPT was compared to 52 industry peers in the Specialty Retail industry. The financial health of ALSPT is average, but there are quite some concerns on its profitability. ALSPT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ALSPT has reported negative net income.

ALSPT had a positive operating cash flow in the past year.

In multiple years ALSPT reported negative net income over the last 5 years.

In multiple years ALSPT reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -2.62%, ALSPT is doing worse than 65.38% of the companies in the same industry.

The Return On Equity of ALSPT (-7.89%) is worse than 67.31% of its industry peers.

With a decent Return On Invested Capital value of 7.75%, ALSPT is doing good in the industry, outperforming 69.23% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-2.62%
ROE	-7.89%
ROIC	7.75%

ROA(3y)-3.05%

ROA(5y)-1%

ROE(3y)-9.05%

ROE(5y)-1.75%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALSPT has a better Operating Margin (3.72%) than 61.54% of its industry peers.

ALSPT's Operating Margin has improved in the last couple of years.

ALSPT has a better Gross Margin (50.88%) than 75.00% of its industry peers.

ALSPT's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	3.72%
PM (TTM)	N/A
GM	50.88%

OM growth 3Y26.27%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.43%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALSPT is still creating some value.

Compared to 1 year ago, ALSPT has more shares outstanding

The debt/assets ratio for ALSPT has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.69, we must say that ALSPT is in the distress zone and has some risk of bankruptcy.

ALSPT has a Altman-Z score of 1.69. This is comparable to the rest of the industry: ALSPT outperforms 46.15% of its industry peers.

The Debt to FCF ratio of ALSPT is 3.41, which is a good value as it means it would take ALSPT, 3.41 years of fcf income to pay off all of its debts.

ALSPT's Debt to FCF ratio of 3.41 is amongst the best of the industry. ALSPT outperforms 80.77% of its industry peers.

A Debt/Equity ratio of 0.50 indicates that ALSPT is somewhat dependend on debt financing.

ALSPT has a Debt to Equity ratio (0.50) which is in line with its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	3.41
Altman-Z	1.69

ROIC/WACC1.34

WACC5.76%

2.3 Liquidity

ALSPT has a Current Ratio of 1.83. This is a normal value and indicates that ALSPT is financially healthy and should not expect problems in meeting its short term obligations.

ALSPT has a better Current ratio (1.83) than 80.77% of its industry peers.

ALSPT has a Quick Ratio of 1.83. This is a bad value and indicates that ALSPT is not financially healthy enough and could expect problems in meeting its short term obligations.

ALSPT has a Quick ratio of 0.70. This is in the better half of the industry: ALSPT outperforms 61.54% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.83
Quick Ratio	0.7

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALSPT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.17%.

ALSPT shows a decrease in Revenue. In the last year, the revenue decreased by -8.71%.

Measured over the past years, ALSPT shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.

EPS 1Y (TTM)-24.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1334.69%

Revenue 1Y (TTM)-8.71%

Revenue growth 3Y-4.6%

Revenue growth 5YN/A

Sales Q2Q%-6.86%

3.2 Future

The Earnings Per Share is expected to decrease by 0.00% on average over the next years.

The Revenue is expected to decrease by -0.51% on average over the next years.

EPS Next Y-150%

EPS Next 2Y73.21%

EPS Next 3Y0%

EPS Next 5YN/A

Revenue Next Year-4.74%

Revenue Next 2Y-1.1%

Revenue Next 3Y-0.51%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPT. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 100.00% of the companies listed in the same industry.

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALSPT indicates a rather cheap valuation: ALSPT is cheaper than 98.08% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	1.17
EV/EBITDA	1

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y73.21%

EPS Next 3Y0%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALSPT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SPARTOO

EPA:ALSPT (7/14/2025, 7:00:00 PM)

0.39

+0.01 (+1.83%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners35.83%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap7.13M

Analysts82

Price Target0.82 (110.26%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-300%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-4.77%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.05
P/FCF	1.17
P/OCF	1.09
P/B	0.24
P/tB	0.29
EV/EBITDA	1

EPS(TTM)-0.13

EYN/A

EPS(NY)-0.1

Fwd EYN/A

FCF(TTM)0.33

FCFY85.56%

OCF(TTM)0.36

OCFY92.11%

SpS7.14

BVpS1.62

TBVpS1.35

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.62%
ROE	-7.89%
ROCE	10.54%
ROIC	7.75%
ROICexc	11.61%
ROICexgc	13.8%
OM	3.72%
PM (TTM)	N/A
GM	50.88%
FCFM	4.68%

ROA(3y)-3.05%

ROA(5y)-1%

ROE(3y)-9.05%

ROE(5y)-1.75%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y13.91%

ROICexcg growth 5YN/A

ROICexc growth 3Y13.21%

ROICexc growth 5YN/A

OM growth 3Y26.27%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.43%

GM growth 5YN/A

F-Score3

Asset Turnover1.47

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	3.41
Debt/EBITDA	1.18
Cap/Depr	6.11%
Cap/Sales	0.36%
Interest Coverage	250
Cash Conversion	52.52%
Profit Quality	N/A
Current Ratio	1.83
Quick Ratio	0.7
Altman-Z	1.69

F-Score3

WACC5.76%

ROIC/WACC1.34

Cap/Depr(3y)16.79%

Cap/Depr(5y)31.52%

Cap/Sales(3y)0.76%

Cap/Sales(5y)1.18%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-24.17%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-1334.69%

EPS Next Y-150%

EPS Next 2Y73.21%

EPS Next 3Y0%

EPS Next 5YN/A

Revenue 1Y (TTM)-8.71%

Revenue growth 3Y-4.6%

Revenue growth 5YN/A

Sales Q2Q%-6.86%

Revenue Next Year-4.74%

Revenue Next 2Y-1.1%

Revenue Next 3Y-0.51%

Revenue Next 5YN/A

EBIT growth 1Y59.21%

EBIT growth 3Y20.46%

EBIT growth 5YN/A

EBIT Next Year315.84%

EBIT Next 3Y72.78%

EBIT Next 5YN/A

FCF growth 1Y84.4%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y44.49%

OCF growth 3YN/A

OCF growth 5YN/A

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens